Article
Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr
Busting Silos: Building the Future of Oncology Drug Development
Summary
In our premiere episode, Dr. Ramin Farhood, along with Dr. Kirk Shepard, shares the origin story behind the Oncology Voice Network (OVN)—a bold vision to unite pharma, biotech, academia, and advocacy, breaking down silos that have slowed progress for years.
What does it mean to give oncology drug development a “home”?
In our premiere episode, Dr. Ramin Farhood, along with Dr. Kirk Shepard, shares the origin story behind the Oncology Voice Network (OVN)—a bold vision to unite pharma, biotech, academia, and advocacy, breaking down silos that have slowed progress for years.
Hear how the book ‘Voices of Oncology’ inspired conversations among industry leaders, and discover how those insights gave rise to a living, breathing network built on shared knowledge and real collaboration.
See how OVN is redefining what’s possible in cancer innovation. Listen to #OncologyVoiceNetwork now!
Related Topics
You May Also Like
Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr
Article
Alyson Haslam, PhD; Vinay Prasad, MD, MPH
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Article
Ali Raza Khaki
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
Article
iNIZIO
Expert perspectives live from ASCO® 2025
Article
Tom Caravela
Where Did My Interview Go Wrong?
Article
Nidal Al-Huniti, Yan Feng, Jingyu (Jerry) Yu, Zheng Lu, Mario Nagase, Diansong Zhou, Jennifer Sheng